Cargando…
Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis
SIMPLE SUMMARY: Hepatocellular carcinoma stands as a major contributor to cancer-related mortality worldwide. This research is aimed at gaining a comprehensive understanding of the pathogenesis of liver cancer, particularly focusing on the potential role of the traditional Chinese herbal medicine As...
Autores principales: | Ma, Yang, Li, Yan, Wu, Taotao, Li, Yingshuai, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605108/ https://www.ncbi.nlm.nih.gov/pubmed/37894415 http://dx.doi.org/10.3390/cancers15205048 |
Ejemplares similares
-
Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021) -
Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection
por: Song, Ke, et al.
Publicado: (2023) -
Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010) -
Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008) -
Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)